A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Determine the Safety and Efficacy of AMG 827 in Subjects With Inadequately Controlled Asthma.
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Brodalumab (Primary) ; Corticosteroids
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Amgen
- 07 Nov 2013 Results published in the American Journal of Respiratory and Critical Care Medicine.
- 26 Feb 2013 Primary endpoint 'Asthma-Control-Questionnaire' has not been met.
- 26 Feb 2013 Results presented at the 69th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History